Edition: India  
> >

Change in Nexstim Plc's Management Team

GlobeNewswire Thursday, 12 October 2017 ()
* Company announcement, Helsinki, 12 October 2017 at 9 AM. * * *

*Change in Nexstim Plc's Management Team*

Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" *Nexstim* " or " *Company* "), a  medical  technology company developing and marketing pioneering navigated  non-invasive  brain stimulation systems for both therapeutic  and diagnostic  applications announces that Hanna Kotola, Vice President of Legal Affairs, has been appointed to undertake the wider role of Quality & Regulatory Affairs, in addition to her current role. Hanna will assume the new position of Vice President Legal, Quality & Regulatory Affairs with immediate effect.

Hanna Kotola joined Nexstim in June 2017 as Vice President of Legal Affairs and has broad international experience having held senior Legal and HR positions in Polar Electro Oy, Digita Oy and Nokia Oyj.

Hanna will be supported in her new extended role by Anna Honkanen, Senior Manager, Quality & Regulatory Affairs. Anna Honkanen has various relevant experience, most recently as an entrepreneur, consulting on quality management systems and regulatory affairs in In Vitro Diagnostic and medical devices companies. Prior to this, Anna acted as Vice President, Quality Management at Orion Diagnostica Oy, a Finnish producer for diagnostic tests systems, and as Director, Quality and Human Resources and Director, Quality Assurance at Oy Medix Biochemica Ab, a Finnish manufacturer of antibodies and diagnostic tests. Anna will join Nexstim on 17 ^th October.

*Martin Jamieson, Chairman and CEO, Nexstim Plc commented:*

"We are delighted to appoint Hanna Kotola to the position of Vice President Legal, Quality & Regulatory Affairs where she is well positioned to ensure the highest quality standards within Nexstim. We also look forward to welcoming Anna Honkanen to our Quality & Regulatory Affairs team. With these appointments, we are well positioned to progress our current and future regulatory filings as part of our strategy to commercialise the NBT® System for therapeutic applications in the US."

Martin Jamieson, CEO

*Further information is available on the website* www.nexstim.com *or by contacting:*

Martin Jamieson, CEO                                                +44 77 1516 3942martin.jamieson@nexstim.com

*UB Securities Oy* (Certified Adviser)                                                                   +358 (0)9 2538 0246

*Citigate Dewe Rogerson*                                     +44 (0)207 2822949
David Dible/Shabnam Bashir/Isabelle Andrews                                     david.dible@citigatedr.co.uk

*About Nexstim Plc*
Nexstim is a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic (NBT® system) and diagnostic (NBS system) applications. Nexstim's NBS system is the only FDA cleared and CE marked system based on navigated Transcranial Magnetic Stimulation (nTMS) for the pre-surgical mapping of the speech and motor cortices of the brain. Based on the same technology platform, the Company has developed the Navigated Brain Therapy (NBT®) which is CE marked in Europe for the treatment of stroke, major depression and chronic neuropathic pain.

Nexstim recently filed a 510(k) submission with FDA for NBT® system for the treatment of Major Depressive Disorder (MDD). Nexstim looks forward to introducing the NBT® system for this important indication in early 2018. The NBT® system is currently in a supplemental Phase III study, E-FIT trial, which will recruit 60 patients. The trial is expected to complete in Q2 2018, allowing Nexstim to file for FDA clearance. FDA clearance would allow Nexstim to start marketing and selling its NBT® system for stroke rehabilitation in the USA.

Nexstim shares are listed on the Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com

Change in Nexstim Plc's Management Team
--------------------This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Nexstim Oyj via GlobeNewswire

Share on
Share on
Post on 
Share by

You Might Like

Other recent news in Press Releases

KBRA Assigns Preliminary Ratings to Prosper Marketplace Issuance Trust, SERIES 2017-3Ultimate SOFTWARE Reveals Xander AI Platform for HCM and Comprehensive Partner Integration Ecosystem at HR Technology Conference
EUROPE's Top 5 Armored Vehicle Manufacturers 2017-2021 - BAE Systems, GDELS, Rheinmetall, KNDS, Iveco Defense Comparative SWOT & Strategy Focus - Research and MarketsAerohive Recognized by The CHANNEL Company for Exceptional Commitment to the CHANNEL
SPECTRUM Health Systems Opens and Expands Addiction Treatment Centers in MassachusettsEast and West Malaysia Gain Enhanced Mobile BROADBAND with SES Networks and CompuDyne
Mining Investment LONDON Conference - November 26th-27th, 2017 - Research and MarketsThe New Foldable ZTE AXON M with Dual Screens Transforms the Mobile Entertainment Experience
Texas COALITION for Affordable Power: Electricity Complaints Fall to New LowPacific LIFE INSURANCE Company and Pacific LifeCorp Announce Pricing and Upsizing of Tender Offer


Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2017 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter